Upgrade to SI Premium - Free Trial

Valeant Pharma (VRX) Announces Receipt of Lender Consent For Credit Facility Amendment

April 7, 2016 7:31 AM
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) announced that it has obtained the requisite lender approval for the amendment and waiver ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Hot Corp. News Litigation Short Sales Trader Talk

Next Articles